retina

New biomarker may predict treatment response in DMEResearchers have identified a new biomarker they believe can be used as a predictor of vision change in patients with diabetic macular edema, either during the natural history of the disease or after undergoing anti-VEGF therapy. The biomarker is disorganization of the retinal inner layers, or DRIL.
How to manage retinal disease in pregnant patients
How to manage retinal disease in pregnant patientsPregnant patients require special care and surveillance when retinal diseases are present.
Roles of Klotho and Endothelin-1 in pseudoexfoliationSerum and aqueous levels of Klotho levels are reduced in pseudoexfoliation syndrome (PXF) and pseudoexfoliative glaucoma (PEG) while Endothelin-1 (ET-1) is increased, researchers say.
16 most popular stories of 2016
16 most popular stories of 2016Here is your roundup of what made top news in 2016!
New study affirms promise of anti-integrin drug for DME
New study affirms promise of anti-integrin drug for DMEA new class of ophthalmic drug continues to show promise for treating patients with diabetic macular edema (DME).
Future of DME resting on new mechanisms of actionWhen it comes to finding new treatments for diabetic macular edema (DME), there is no shortage of promising targets, said Peter A. Campochiaro, MD. He presented an overview of future compounds with various mechanisms of action that may change how clinicians treat DME.
Introducing 3-D OCT to live surgery
Introducing 3-D OCT to live surgeryThe advent of three-dimensional optical coherence tomography to live surgery may bring greater clarity to how ophthalmologists visualize structures and how they operate.
Researchers reject vitamin D role in macular degeneration
Researchers reject vitamin D role in macular degenerationAnalyzing data from the European Eye Study, Gareth J. McKay, PhD, of Queen’s University in Belfast, United Kingdom, and colleagues in 7 countries in Europe found no meaningful association between serum 25-hydroxy vitamin D (25(OH)D) and AMD. They published the finding in Ophthalmology.
Choosing the right treatment for proliferative diabetic retinopathy
Choosing the right treatment for proliferative diabetic retinopathyRetina specialists who are Diabetic Retinopathy Clinical Research Network investigators offer views on whether laser panretinal photocoagulation or anti-VEGF therapy deserves consideration as first-line treatment for proliferative diabetic retinopathy.
Visual phenomena, decreased vision secondary to occipital lobe infarct
Visual phenomena, decreased vision secondary to occipital lobe infarctMicroperimetry aids diagnosis, and supplements increase circulation